Pannell, N.Joseph, DarrenAlly, Mahmood Moosa Tar MahomedBida, Nndweleni MeshackTintinger, Gregory Ronald2022-06-232022-06-232021Pannell, N., Joseph, D., Ally, M.M.T.M. et al. 2021, 'Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritis', African Journal of Thoracic and Critical Care Medicine, vol. 27, no. 3, pp. 123-125, doi : 10.7196/AJTCCM.2021.v27i3.116 .2617-020510.7196/AJTCCM.2021.v27i3.116https://repository.up.ac.za/handle/2263/85933Patients with rheumatoid arthritis (RA) may receive Janus kinase (JAK) inhibitors to achieve optimal control of their disease. We report a case of a patient who received a selective JAK1 inhibitor and subsequently developed multiple pulmonary nodules with cavitation. Biopsies confirmed the presence of cryptococcosis and the patient responded well to anti-fungal therapy.enSouth African Medical AssociationJanus kinase inhibitorsOpportunistic infectionsRheumatoid arthritis (RA)Pulmonary nodules associated with JAK inhibitor therapy in rheumatoid arthritisArticle